Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

700 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ranking the harm of non-medically used prescription opioids in the UK.
van Amsterdam J, Phillips L, Henderson G, Bell J, Bowden-Jones O, Hammersley R, Ramsey J, Taylor P, Dale-Perera A, Melichar J, van den Brink W, Nutt D. van Amsterdam J, et al. Among authors: van den brink w. Regul Toxicol Pharmacol. 2015 Dec;73(3):999-1004. doi: 10.1016/j.yrtph.2015.09.014. Epub 2015 Sep 14. Regul Toxicol Pharmacol. 2015. PMID: 26382614
Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients.
Rook EJ, van Ree JM, van den Brink W, Hillebrand MJ, Huitema AD, Hendriks VM, Beijnen JH. Rook EJ, et al. Among authors: van ree jm, van den brink w. Basic Clin Pharmacol Toxicol. 2006 Jan;98(1):86-96. doi: 10.1111/j.1742-7843.2006.pto_233.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16433897 Free article. Clinical Trial.
Ranking of drugs: a more balanced risk-assessment.
van Amsterdam J, van den Brink W. van Amsterdam J, et al. Among authors: van den brink w. Lancet. 2010 Nov 6;376(9752):1524-5. doi: 10.1016/S0140-6736(10)62000-4. Epub 2010 Oct 29. Lancet. 2010. PMID: 21036391 No abstract available.
Harm potential of magic mushroom use: a review.
van Amsterdam J, Opperhuizen A, van den Brink W. van Amsterdam J, et al. Among authors: van den brink w. Regul Toxicol Pharmacol. 2011 Apr;59(3):423-9. doi: 10.1016/j.yrtph.2011.01.006. Epub 2011 Jan 21. Regul Toxicol Pharmacol. 2011. PMID: 21256914 Review.
Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands.
van Amsterdam JG, van Laar M, Brunt TM, van den Brink W. van Amsterdam JG, et al. Among authors: van laar m, van den brink w. Regul Toxicol Pharmacol. 2012 Jun;63(1):55-63. doi: 10.1016/j.yrtph.2012.03.005. Epub 2012 Mar 14. Regul Toxicol Pharmacol. 2012. PMID: 22440552
Generic legislation of new psychoactive drugs.
van Amsterdam J, Nutt D, van den Brink W. van Amsterdam J, et al. Among authors: van den brink w. J Psychopharmacol. 2013 Mar;27(3):317-24. doi: 10.1177/0269881112474525. Epub 2013 Jan 23. J Psychopharmacol. 2013. PMID: 23343598
700 results